Earlier works by others have demonstrated that advanced melanoma patients with BRAF mutations not only have an increased risk of developing BrM, but also have a shorter disease-free interval from primary diagnosis to diagnosis of BrM [31]. The gene discussed is BRAF; the disease is melanoma.